Central nervous system relapse in a patient with acute promyelocytic leukaemia treated with arsenic tri-oxide [3]

British Journal of Haematology

Volumn 113, Issue 1, 2001, Pages 257-258

  Mathews, V ^a   Balasubramanian, P ^a   Shaji, R V ^a   George, B ^a   Chandy, M ^a   Srivastava, A ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Acute promyelocytic leukaemia; Arsenic trioxide; Central nervous system; Extramedullary; Relapse

Indexed keywords

ARSENIC TRIOXIDE;

ACUTE MYELOBLASTIC LEUKEMIA; ADULT; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CENTRAL NERVOUS SYSTEM DISEASE; HUMAN; KARYOTYPING; LETTER; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0035010711     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2001.02673-4.x     Document Type: Letter

References (6)

1. Central nervous system relapse in acute promyelocytic leukaemia in patients treated with all-trans retinoic acid
2. Studies on treatment of acute promyelocytic leukemia with arsenic trioxide: Remission induction, follow up, and molecular monitoring in 11 newly diagnosed and 47 relapsed acute promyelocytic leukemia patients
3. Use of arsenic trioxide in the treatment of acute promyelocytic. Leukemia II. Clinical efficacy and pharmacokinetics in relapsed patients
4. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide
5. Two cases of extrarnedullary acute promyelocytic leukemia
6. Choroid plexus protects cerebrospinal fluid against toxic metals